Skip to main content
ISTH 2024 Main banner
Back

Pål Andrè Holme, MD, PhD, MBA

Professor
Department of Hematology, Oslo University Hospital, Oslo, Norway
Oslo, Oslo, Norway

Professor Pål André Holme, MD, PhD, MBA

Department of Haematology, Oslo University Hospital, Rikshospitalet and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Pål André Holme is Professor of Haematology and Senior Haematologist at the Department of Haematology and Institute of Clinical Medicine, Oslo University and Oslo University Hospital, Rikshospitalet, Norway. He is the Head of the Department of Haematology, Oslo University Hospital. He graduated from the Medical School at the University of Oslo in 1993 and was a research fellow at the Institute for Internal Medicine, University of Oslo, where he earned a PhD in 1996 after studies on platelet activation and platelet-derived-microparticle formation. He is a specialist in internal medicine and haematology.

Prof Holme has been responsible for the treatment of adult patients with haemophilia and bleeding related disorders in Norway since 2006. He leads a research group at Institute of Clinical Medicine and participates in several clinical research groups and has for a long time been an active investigator in studies on thrombosis, bleeding related disorders and platelets. He and his group were also the first to report on devastating side effects after ChAdOx1 nCoV-19 vaccination and named it VITT- Vaccine-induced immune thrombotic thrombocytopenia. He has authored numerous papers published in peer-reviewed journals and textbook chapters on these subjects.

Presentation(s):